IBRX Operating Expenses

Immunitybio Inc · Operating Expenses

IBRX logo

IBRX Operating Expenses

Latest reported$408.68M
IBRX TTM Operating Expenses ($124.52M → $408.68M)
High-resolution chart · PNG

IBRX operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Immunitybio Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
408,682,000
393,617,000
360,746,000
338,977,000
341,773,000
344,579,000
358,927,000
367,503,000
361,362,000
346,168,000
356,594,000
348,480,000
353,209,000
341,749,000
326,665,000
328,915,000
322,870,000
335,389,000
331,214,000
280,210,000
267,336,000
232,443,000
182,907,000
175,766,000
125,815,000
91,776,000
73,249,000
69,456,000
77,518,000
88,487,000
98,436,000
106,116,000
106,427,000
101,979,000
99,165,000
98,917,000
107,254,000
118,397,000
124,517,000
179,296,000
189,313,000
238,510,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.